Taking the guesswork out of cancer therapy
Researchers and doctors at the Institute of Bioengineering and Nanotechnology (IBN), Singapore General Hospital (SGH) and National Cancer Centre Singapore (NCCS) have co-developed the first molecular test kit that can predict treatment and survival outcomes in kidney cancer patients. According to IBN Executive Director Professor Jackie Y. Ying, “By combining our expertise in molecular diagnostics […]
